Barrow Robert bought DFTX
June 22, 2026 · Form 4 insider transaction
Barrow Robert bought 375,000 shares of Definium Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
375,000
Price
$0.00
Total value
N/A
InsiderBarrow Robert
RoleOfficer, Director
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateJune 22, 2026
Filing dateJune 22, 2026
Shares owned after1,127,454
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The common shares represent the first tranche of performance share units granted effective March 12, 2025, and remain subject to vesting based on the Reporting Person's continued employment through March 12, 2028. Each performance share unit represented a contingent right to receive one common share based on, and subject to, the achievement of certain clinical and regulatory milestones set forth in the Performance Share Unit Award Agreement.